Meperidine Market Trends, Future Outlook, COVID-19 Impact Analysis, Forecast 2022-2028

The meperidine market is expected to grow at a steady growth rate during the forecast period. The drug is sold under a brand name Demerol, manufactured by Pfizer Inc. It is a drug of class opioid (narcotic) analgesics that is similar to morphine. Due to this, in most of the countries, the drug is not available over-the-counter (OTC) and needs a prescription to purchase it. The drug manipulates the mechanism of the brain and changes the way the body feels and responds to pain. The drug is used to relieve a person from moderate to severe pain. Moreover, it can be used by doctors before or during surgery or other procedures. However, the drug cannot be used to treat long-term or on-going pain and is used only when the pain is sudden. Moreover, misuse of the drug can cause addiction to it and even death.

A full report of Meperidine Market is available at: https://www.omrglobal.com/industry-reports/meperidine-market

An increase in surgical procedures all across the globe is one of the major factors for the growth of the market during the forecast period. As per the International Society of Aesthetic Plastic Surgery, around 10.6 million surgical procedures whereas around 12.6 million non-surgical procedures were performed all across the globe in 2018. In terms of surgical procedure, the overall growth of 15.0% was witnessed in the period of 2014 and 2018, whereas in the non-surgical procedure, the overall growth was 24.5% registered for the same period mentioned earlier. The US had witnessed most non-surgical procedures with around 2.8 million non-surgical procedures in 2018. However, Brazil has registered most surgical procedures with around 1.5 million surgical procedures in 2018.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/meperidine-market

Disadvantages associated with the drug and availability of alternatives are among the major factor restraining the growth of the market. Nausea, vomiting, constipation, sweating, lightheadedness, dizziness, and drowsiness are some of the common side effects of the drug. One can also get addicted to the drug due to which it is a schedule II controlled substance. Sometimes, it is also illegally available to the people which they intake it by chewing, crushing to the powder, or dissolving it to the water. Moreover, the drug has a number of alternatives available in the market including morphine, hydromorphone, fentanyl, oxycodone, hydrocodone, and codeine. The prescribing rate of opioid in the US is decreasing continuously every year.

As per the Centers for Disease Control and Prevention, the prescription rate of opioid has been decreased from 81.3% of the total prescription in 2012 to 51.4% in 2018. Moreover, the total number of opioid prescriptions has been reduced to 168 million in 2018 as compared to 255 million in 2012.

Global Meperidine Market Report Segment

By Application

• Pain Relief
• Anaesthesia

By Dosage type

• Oral
• Injections

Meperidine Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Boehringer Ingelheim International GmbH
• Neon Laboratories Ltd.
• Pfizer Inc.
• Mallinckrodt plc
• Hikma Pharmaceuticals PLC

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.